1. Home
  2. EHTH vs AQST Comparison

EHTH vs AQST Comparison

Compare EHTH & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo eHealth Inc.

EHTH

eHealth Inc.

HOLD

Current Price

$1.50

Market Cap

104.0M

Sector

Finance

ML Signal

HOLD

Logo Aquestive Therapeutics Inc.

AQST

Aquestive Therapeutics Inc.

HOLD

Current Price

$4.12

Market Cap

521.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EHTH
AQST
Founded
1997
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
104.0M
521.0M
IPO Year
2006
2007

Fundamental Metrics

Financial Performance
Metric
EHTH
AQST
Price
$1.50
$4.12
Analyst Decision
Hold
Strong Buy
Analyst Count
3
5
Target Price
$3.33
$9.00
AVG Volume (30 Days)
1.0M
1.9M
Earning Date
05-06-2026
03-04-2026
Dividend Yield
N/A
N/A
EPS Growth
71.43
N/A
EPS
N/A
N/A
Revenue
$251,395,000.00
$67,430,000.00
Revenue This Year
N/A
$14.23
Revenue Next Year
$5.18
$58.36
P/E Ratio
N/A
N/A
Revenue Growth
45.86
0.77
52 Week Low
$1.20
$2.20
52 Week High
$7.56
$7.55

Technical Indicators

Market Signals
Indicator
EHTH
AQST
Relative Strength Index (RSI) 38.14 50.07
Support Level $1.20 $3.69
Resistance Level $1.93 $4.46
Average True Range (ATR) 0.15 0.21
MACD 0.06 -0.01
Stochastic Oscillator 41.20 39.84

Price Performance

Historical Comparison
EHTH
AQST

About EHTH eHealth Inc.

eHealth Inc is a company involved in private health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. The company operates its business in two segments: Medicare which provides health insurance plans and lesser extent ancillary products such as dental and vision insurance and hospital indemnity plans, to medicare eligible consumers; and Employer and Individual provides individual and family health insurance, and small business health insurance plans and Individual Coverage Health Reimbursement Arrangements. It derives maximum revenue from Medicare Segment. All of the company's revenue is from the United States. It also has a presence in China.

About AQST Aquestive Therapeutics Inc.

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.

Share on Social Networks: